Andrew Cohen (businessman)

Andrew Cohen (born 1977) is an Australian businessman and CEO of leading primary healthcare network Healius Medical & Dental.

For other people named Andrew Cohen, see Andrew Cohen (disambiguation).

Andrew Cohen
Cohen in 2016
Born1977
Melbourne, Australia
NationalityAustralian
EducationUniversity of Melbourne, Cambridge University
OccupationBusinessman

Early life and education

Born in Melbourne in 1977, Cohen attended high school in Melbourne, before completing consecutive bachelor's degrees in Arts (Philosophy) and Commerce (Finance and Accounting) at the University of Melbourne.[1]

Career

Cohen joined management consultancy L.E.K. Consulting as a graduate in 2002, working in the Private Equity and Corporate Mergers and Acquisitions sectors of the firm's Australian and US offices. In 2005, the firm sponsored him to undertake a full-time MBA at Cambridge University where he graduated first in his class.[1][2]

Bain and Company

From 2008 to 2016, Cohen worked as a Consumer Products and Retail advisor with high-profile global management consultancy Bain & Company. In 2014 he was promoted to partner in Bain's Melbourne office.[3][4] His experience in cross-border trade in China, and track record of business turn-arounds during his time as a Partner at Bain & Company[5] saw him recruited as a senior executive at Bellamy's Organic.[6][7]

Bellamy's Organic

Cohen joined Bellamy's Organic in June 2016 as COO & Chief Strategic Officer. Six months later he was appointed acting CEO in January 2017, following departure of former CEO Laura McBain and in the wake of sharemarket unrest, significant regulatory change and a slowdown in China demand. Bellamy's had faced a share price plunge in December and January, after flagging a significant drop in sales and earnings. An investor-led revolt followed, replacing the board of directors and senior management team.[8][9]

In April 2017, with the appointment of John Ho of Hong Kong-based investor Janchor Partners to the board as a non-executive Director and later to Chairman, Bellamy's confirmed Cohen as its permanent chief executive.[10]

From January 2017 to December 2019, Cohen and his team led a high profile and broad reaching transformation of the Bellamy’s business. Despite continued regulatory challenges, significant strategic and operational improvements were made. These included stronger revenues, a significant improvement in margins and profitability, a successful rebrand and product upgrade, and the establishment of a strong new product pipeline and local supply-chain. In December 2019 China Mengniu Dairy, a leading global dairy player, acquired Bellamy’s Australia for $1.5 billion and it was officially removed from the ASX. During the three years shareholder value was increased >3 times from a share price low of $4.14 in January 2017 to the effective offer price of $13.25 per share.[11][12]

Cohen continued in the CEO and Managing Director role as an independent subsidiary of Mengniu Dairy, with a strong focus on growth in China and rising middle-class Asia before stepping down in September 2020 to pursue a new CEO role.[13]

Healius Medical & Dental

Cohen was appointed CEO in November 2020 following a $500m buy-out by Australia's largest Private Equity fund BGH Capital. Healius Medical & Dental is a leading primary healthcare community of more than 3500 healthcare professionals and employees across a growing network of 86 large scale medical centres.[14]

References
  1. "Annual Report 2017". bellamysorganic.com.au. Bellamys Australia. Retrieved 25 October 2017.
  2. Cohen, Andrew. "Profile". LinkedIn. Retrieved 28 October 2017.
  3. "Bain & Company strengthens worldwide partner group with the promotion of 32 business consultants". Bain & Company. Retrieved 26 October 2017.
  4. Delany, Lee; Cohen, Andrew; Morningstar, Tim; Hansen, Odd Erik. "Pricing for Penetration". Bain & Company. Retrieved 28 October 2017.
  5. Perkins, James (11 January 2017). "Laura Mcbain Dumped As Bellamy's Ceo As Its Problems Are Laid Bare". Business News Australia. Retrieved 26 October 2017.
  6. Thompson, Sarah; Macdonald, Anthony; Moullakis, Joyce (14 June 2016). "Bellamy's lures Bain & Co's Andrew Cohen, Powerhouse Ventures ramps up IPO". Australian Financial Review. Retrieved 29 October 2017.
  7. Lynch, Jarrod; Flitton, Daniel; Wen, Phillip (12 April 2016). "Blackmores, Bellamy's Organic, a2 Milk shares plunge on China customs crackdown". Australian Financial Review. Retrieved 29 October 2017.
  8. "Bellamy's Australia says acting CEO Andrew Cohen and acting CFO Nigel Underwood confirmed as permanent executive appointments". Thompson Reuters. 13 April 2017. Retrieved 26 October 2017.
  9. Gardner, Jessica (13 April 2017). "Bellamy's Australia appoints John Ho to board, confirms Andrew Cohen as CEO". Australian Financial Review. Retrieved 26 October 2017.
  10. "Bellamy's interim CEO now permanent". SBS. Australian Associated Press. 13 April 2017. Retrieved 26 October 2017.
  11. "Yahoo! Finance: Bellamy's Australia Limited (BAL.AX)". Yahoo! Finance. Retrieved 5 February 2020.
  12. "Bellamy's shareholders back Chinese dairy group's $1.5b takeover". Sydney Morning Herald. 5 December 2019. Retrieved 5 February 2020.
  13. LaFrenz, Carrie (21 August 2020). "Bellamy's Organic CEO steps down". Australian Financial Review. Retrieved 28 December 2020.
  14. LaFrenz, Carrie (26 November 2020). "Ex-Bellamy's boss tapped to run former Healius medical centres". Australian Financial Review. Retrieved 28 December 2020.
This article is issued from Wikipedia. The text is licensed under Creative Commons - Attribution - Sharealike. Additional terms may apply for the media files.